References
- Ballas, Z. K., Rasmussen, W., and Van Otegham, J. K., Lymphokine-activated killer (LAK). II. Delineation of distinct murine LAK-precursor subpopulation. J. Immunol., 138, 1647-1652 (1987)
- Chen, Y. M, Ting, C. C., Peng, J. W., Yang, W. K., Yang, K. Y., Tsai, C. M., and Perng, R. P., Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin- 15 vs. interleukin-2. J. Interferon Cytokine Res., 20(1), 31-39 (2000) https://doi.org/10.1089/107999000312711
- Doherty, P. C., Grosveld, G. C., and Ihle, J. N., Requirement for Stat4 in interleukin-12-mediated response of natural killer and T cells. Nature, 382, 171-174 (1996) https://doi.org/10.1038/382171a0
- Galdiero, M., Cipollaro del'Ero, G., Folgore, A., Cappello, M., Giobbe, A., and Sasso, F. S., Effects of irradiation doses on alteration in cytokine release by monocytes and lymphocytes. J. Med., 25, 23-40 (1994)
- Gao, Q. P., Kiyohara, H., Cyong, J., and Yamada, H., Chemical properties and anticomplementary activities of heteroglycans from the leaves of panax ginseng. Planta Med., 57, 132-136 (1991) https://doi.org/10.1055/s-2006-960049
- Grimm, E. A., Mazumder, A., Zhang, Z., and Rosenberg, S. A., Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med., 155, 1823-1841 (1982) https://doi.org/10.1084/jem.155.6.1823
- Han, S. K., Song, J. Y., Yun, Y. S., and Yi, S. Y., Gamma irradiation reduced IFN-gamma expression, STAT-1 signal, and cell-mediated immunity. J. Biochem. Mol. Biol., 35(6), 583-589 (2002) https://doi.org/10.5483/BMBRep.2002.35.6.583
- Khan, I. A. and Casciotti, L., IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J. Immunol., 163(8), 4503-4509 (1999)
- Kim, S. I., Kang, K. S., and Lee, Y. H., Panaxyne epoxide, a new cytotoxic polyne from panax ginseng root against L1210 cells. Arch. Pharm. Res., 12, 48-51 (1989) https://doi.org/10.1007/BF02855746
- Kim, Y. S., Kang, K. S., and Kim, S. I., Study on antitumor and immunomodulating activities of polysaccharides fraction from parax ginsans: Comparison of effect of neutral and acidic polysaccharide fraction. Arch. Pharm. Res., 13, 330-337 (1990) https://doi.org/10.1007/BF02858168
- Lee, Y. S., Jung, I. S., Lee, I. R., Kim, K. W., Hong, W. S., and Yun, Y. S., Activation of Multiple Effecter pathway of immune system by the antineoplastic immunostimulator acldic polysaccharide ginsan isolated from panax ginseng. Anticancer Res., 17, 323-331 (1997)
- Maeda, Y. Y., Watanabe, S. T., Chilara, G., and Rokutanda, M., T-cell mediated vascular dilation and hemorrhage induced by antitumor polysaccharide. Intl. J. Immunopharmacol, 6, 493- 501 (1984) https://doi.org/10.1016/0192-0561(84)90088-2
- Mule, J. J., Shu, S., and Rosenberg, S., The antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo. J. Immunol., 135, 646-652 (1985)
- Murren, J. R. and Buzaid, A. C., The role of interferons in the treatment of malignant neoplasms. Yale J. Biol. Med., 62, 271-290 (1989)
- Ochoa, A. C., Gromo, G., Alter, B. J., Sondel, P. M., and Bach, F. II., Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, bIL-1, interferon-g and -b. J. immunol., 138, 2728-2733 (1987)
- Oldham, R. K., Biological response modifiers program and chemotheraphy. Int. J. Tissue React., 4, 173-188 (1982)
- Pharmacognosy, Korea association of pharmacognosy, hakchang press (1995)
- Rosenberg, S., Lotze, M., Muul, L., Leitman, S., Chang, A., Ettinghausen, S., Matury, Y., Skibber, J., Shilon, E., Vetto, J., Seipp, C., Simpson, C., and Reichert, C., Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485-1492 (1985)
- Shuat, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., and Darnell, J. E., Interferon activation of transcription factor Stat1 involves dimerization through SH2- Phosphotyrosyl peptide interactions. Cell, 76, 821-828 (1994) https://doi.org/10.1016/0092-8674(94)90357-3
- Singh, V. K., George, C. X., Singh, N., Agarwal, S. S., and Gupta, B. M., Combined treatment of mice with Panax ginseng extract and interferon inducer. Planta Med., 47, 234- 236 (1983) https://doi.org/10.1055/s-2007-969995
- Smalley, R. V. and Oldham, R. K., Phase I trials of biological response modifiers. Drugs Exptl. Clin. Res., 12, 31-39 (1986)
- Song, J. Y., Han, S. K., Bae, K. G., Lim, D. S., Son, S. J., Jung, I. S., Yi, S. I., and Yun, Y. S., Radioprotective effects of Ginsan, an immunomodulator. Radiat. Res., 159(6), 768-774 (2003) https://doi.org/10.1667/0033-7587(2003)159[0768:REOGAI]2.0.CO;2
- Song, J. Y., Han, S. K., Son, E. H., Pyo, S. N., Yun, Y. S., Yi, S. Y., Induction of secretory and tumoricidal activities in peritoneal macrophages by Ginsan. Int. Immunopharmacol., 2(7), 857-865 (2002) https://doi.org/10.1016/S1567-5769(01)00211-9
- Sredni, B., Caspi, R.R., Klein, A., Kalechman, Y., Danziger, Y., BenYa'akov, M., Tamari, T., Shalit, F., and Albeck, M., A new immunomodulating compound (AS101) with potential therapeutic application. Nature, 330, 173-176 (1987) https://doi.org/10.1038/330173a0
- Strander, H., Clinical effects of interferon therapy with special emphasis on antitumor efficacy. Acta Oncologica, 28, 355- 362 (1989) https://doi.org/10.3109/02841868909111206
- Talmadge, J. E. and Herberman, R. B., The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treatment Reports, 70, 171-182 (1986)
- Talmadge, J. E., Fidler, I. J., and Oldham, R. K., The NCI preclinical screen of biological response modifiers. Behring Inst. Mitt., 74, 189-194 (1984)
- Uchida and Micksche, M., In vitro augmentation of natural killing activity by OK-432. Int. J. Immunopharmac., 3, 365-375 (1981) https://doi.org/10.1016/0192-0561(81)90032-1
- Wiltrout, R. H. and Hornung, R. L., natural products as antitumor agents: direct versus indirect mechanisms of activity of flavonoids. J. Natl.Cancer Institute, 80, 220-222 (1988) https://doi.org/10.1093/jnci/80.4.220
- Wimer, B. M., The ideal biological response modifier. Mol. Biother., 1, 311-317 (1989)
- Yanagawa, E., Yasumoto, K., Ohta, M., Nomoto, K., Azuma, I., and Yamamura, Y., Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency. JPN. J. Cancer Res., 70, 141-146 (1979)
- Yang, J. C., Mule, J. J., and Rosenberg, S., Murine lymphokineactivated killer (LAK) cells: phenotypic characterization of the precursors and effector cells. J. Immunol., 137, 715-722 (1986)
- Yun, Y.-S., Lee, Y.-S., Jo, S.-K., and Jung, I.-S., Inhibition of autochthonous tumor by ethanol insoluble fraction from panax ginseng as an immunostimulator. Planta medica, 59, 521-524 (1993) https://doi.org/10.1055/s-2006-959752